[Relationship of cyclooxygenase-2 and multidrug resistance associated factors to chemosensitivities in gastrointestinal carcinomas].
Bibo Tan, Yong Li, Jie Han, Li-Qiao Fan, Qun Zhao, Zhenchuan Song, Dong Wang
Abstract
Bibo Tan, Yong Li, Jie Han, Li-Qiao Fan, Qun Zhao, Zhenchuan Song, Dong Wang
Abstract
OBJECTIVE: To investigate the relationship of cyclooxygenase-2 (COX-2), p-glycoprotein(P-gp), glutathione S-transferase-pi (GST-pi), and topoisomerase II alpha (Topo II alpha) to chemosensitivities in gastrointestinal tract carcinomas. METHODS: The tumor tissue samples were collected from 84 specimens of gastrointestinal carcinomas. The expressions of COX-2, P-gp, GST-pi, and Topo II alpha were determined immunohistochemically. The chemosenisitivity of each sample to 9 drugs were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. RESULTS: The positive rates of COX-2, P-gp, GST-pi and Topo II alpha were 48.8%, 76.2%, 78.6% and 66.7% respectively. The expression of COX-2 was correlated with the expression of P-gp and Topo II alpha significantly (r = 0.287, 0.256, both P < 0.05). In terms of relationships of four MDR-related factors expression to inhibition rate of tumor cells, the inhibition rates of PTX, eADM and OPT in COX-2 strong expression group were significantly lower than those in COX-2 weak expression group (t = 2.21, 3.11, 2.09; all P < 0.05). The inhibition rates of PTX, OXA and DDP in P-gp strong expression group were lower than those in weak group (t = 2.54, 2.47, 2.05; all P < 0.05). There were lower inhibition rates for 5-Fu in GST-pi strong expression group (t = 2.13, P < 0.05), and higher inhibition rates for VCR, PTX and eADM in TopoII alpha strong expression group (t = -2.29, -2.12, - 2.26, all P < 0.05). CONCLUSIONS: The overexpressions of MDR-related factors in gastrointestinal carcinomas were only associated with the chemosensitivity to some of the chemotherapeutic agents, but not all. MDR related factors may be not specific and accurate predictors for the clinical chemosensitivity.
OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
OBJECTIVE: To investigate the relationship of cyclooxygenase-2 (COX-2), p-glycoprotein(P-gp), glutathione S-transferase-pi (GST-pi), and topoisomerase II alpha (Topo II alpha) to chemosensitivities in gastrointestinal tract carcinomas. METHODS: The tumor tissue samples were collected from 84 specimens of gastrointestinal carcinomas. The expressions of COX-2, P-gp, GST-pi, and Topo II alpha were determined immunohistochemically. The chemosenisitivity of each sample to 9 drugs were measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. RESULTS: The positive rates of COX-2, P-gp, GST-pi and Topo II alpha were 48.8%, 76.2%, 78.6% and 66.7% respectively. The expression of COX-2 was correlated with the expression of P-gp and Topo II alpha significantly (r = 0.287, 0.256, both P < 0.05). In terms of relationships of four MDR-related factors expression to inhibition rate of tumor cells, the inhibition rates of PTX, eADM and OPT in COX-2 strong expression group were significantly lower than those in COX-2 weak expression group (t = 2.21, 3.11, 2.09; all P < 0.05). The inhibition rates of PTX, OXA and DDP in P-gp strong expression group were lower than those in weak group (t = 2.54, 2.47, 2.05; all P < 0.05). There were lower inhibition rates for 5-Fu in GST-pi strong expression group (t = 2.13, P < 0.05), and higher inhibition rates for VCR, PTX and eADM in TopoII alpha strong expression group (t = -2.29, -2.12, - 2.26, all P < 0.05). CONCLUSIONS: The overexpressions of MDR-related factors in gastrointestinal carcinomas were only associated with the chemosensitivity to some of the chemotherapeutic agents, but not all. MDR related factors may be not specific and accurate predictors for the clinical chemosensitivity.
Key concepts: Cyclooxygenase, P-glycoprotein, Chemistry, Multiple drug resistance, Internal medicine, Medicine, Enzyme, Biochemistry